Literature DB >> 22328862

Synthesis of bombesin-functionalized iron oxide nanoparticles and their specific uptake in prostate cancer cells.

Amanda L Martin1, Jennifer L Hickey, Amber L Ablack, John D Lewis, Leonard G Luyt, Elizabeth R Gillies.   

Abstract

The imaging of molecular markers associated with disease offers the possibility for earlier detection and improved treatment monitoring. Receptors for gastrin-releasing peptide are overexpressed on prostate cancer cells offering a promising imaging target, and analogs of bombesin, an amphibian tetradecapeptide have been previously demonstrated to target these receptors. Therefore, the pan-bombesin analog [β-Ala11, Phe13, Nle14]bombesin-(7-14) was conjugated through a linker to dye-functionalized superparamagnetic iron oxide nanoparticles for the development of a new potential magnetic resonance imaging probe. The peptide was conjugated via click chemistry, demonstrating a complementary alternative methodology to conventional peptide-nanoparticle conjugation strategies. The peptide-functionalized nanoparticles were then demonstrated to be selectively taken up by PC-3 prostate cancer cells relative to unfunctionalized nanoparticles and this uptake was inhibited by the presence of free peptide, confirming the specificity of the interaction. This study suggests that these nanoparticles have the potential to serve as magnetic resonance imaging probes for the detection of prostate cancer.

Entities:  

Year:  2009        PMID: 22328862      PMCID: PMC3276591          DOI: 10.1007/s11051-009-9681-3

Source DB:  PubMed          Journal:  J Nanopart Res        ISSN: 1388-0764            Impact factor:   2.253


  49 in total

1.  High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates.

Authors:  L Josephson; C H Tung; A Moore; R Weissleder
Journal:  Bioconjug Chem       Date:  1999 Mar-Apr       Impact factor: 4.774

2.  Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study.

Authors:  C Van de Wiele; F Dumont; R Vanden Broecke; W Oosterlinck; V Cocquyt; R Serreyn; S Peers; J Thornback; G Slegers; R A Dierckx
Journal:  Eur J Nucl Med       Date:  2000-11

3.  A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent.

Authors:  R La Bella; E Garcia-Garayoa; M Bahler; P Bläuenstein; R Schibli; P Conrath; D Tourwé; P A Schubiger
Journal:  Bioconjug Chem       Date:  2002 May-Jun       Impact factor: 4.774

4.  Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles.

Authors:  Mikael J Pittet; Filip K Swirski; Frederick Reynolds; Lee Josephson; Ralph Weissleder
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 5.  How good is MRI at detecting and characterising cancer within the prostate?

Authors:  Alexander P S Kirkham; Mark Emberton; Clare Allen
Journal:  Eur Urol       Date:  2006-06-30       Impact factor: 20.096

6.  Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells.

Authors:  Timothy J Hoffman; Hariprasad Gali; C Jeffrey Smith; Gary L Sieckman; Donald L Hayes; Nellie K Owen; Wynn A Volkert
Journal:  J Nucl Med       Date:  2003-05       Impact factor: 10.057

Review 7.  Imaging in the era of molecular oncology.

Authors:  Ralph Weissleder; Mikael J Pittet
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

8.  Radiochemical investigations of gastrin-releasing peptide receptor-specific [(99m)Tc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X = H2O or P(CH2OH)3.

Authors:  C Jeffrey Smith; Gary L Sieckman; Nellie K Owen; Donald L Hayes; Dana G Mazuru; Raghuraman Kannan; Wynn A Volkert; Timothy J Hoffman
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

9.  The contractile effect of bombesin, gastrin releasing peptide and various fragments in the rat stomach strip.

Authors:  F Girard; H Bachelard; S St-Pierre; F Rioux
Journal:  Eur J Pharmacol       Date:  1984-07-20       Impact factor: 4.432

10.  Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells.

Authors:  R S Molday; D MacKenzie
Journal:  J Immunol Methods       Date:  1982-08-13       Impact factor: 2.303

View more
  14 in total

Review 1.  Insights into bombesin receptors and ligands: Highlighting recent advances.

Authors:  Irene Ramos-Álvarez; Paola Moreno; Samuel A Mantey; Taichi Nakamura; Bernardo Nuche-Berenguer; Terry W Moody; David H Coy; Robert T Jensen
Journal:  Peptides       Date:  2015-05-11       Impact factor: 3.750

Review 2.  Cancer theranostics: the rise of targeted magnetic nanoparticles.

Authors:  Adam J Cole; Victor C Yang; Allan E David
Journal:  Trends Biotechnol       Date:  2011-04-12       Impact factor: 19.536

Review 3.  Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment.

Authors:  Paola Moreno; Irene Ramos-Álvarez; Terry W Moody; Robert T Jensen
Journal:  Expert Opin Ther Targets       Date:  2016-03-28       Impact factor: 6.902

4.  Design and Application of Magnetic-based Theranostic Nanoparticle Systems.

Authors:  Aniket S Wadajkar; Jyothi U Menon; Tejaswi Kadapure; Richard T Tran; Jian Yang; Kytai T Nguyen
Journal:  Recent Pat Biomed Eng       Date:  2013-04-01

5.  Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer.

Authors:  Sophie Laurent; Morteza Mahmoudi
Journal:  Int J Mol Epidemiol Genet       Date:  2011-11-25

6.  Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing Peptide receptors.

Authors:  Nicole F Steinmetz; Amber L Ablack; Jennifer L Hickey; Jailal Ablack; Bhavik Manocha; Joe S Mymryk; Leonard G Luyt; John D Lewis
Journal:  Small       Date:  2011-04-26       Impact factor: 13.281

Review 7.  Functionalized nanoparticles targeting biomarkers for prostate cancer imaging and therapy.

Authors:  Ankur U Choksi; Amir I Khan; Soum D Lokeshwar; Daniel Segal; Robert M Weiss; Darryl T Martin
Journal:  Am J Clin Exp Urol       Date:  2022-06-15

Review 8.  Novel delivery approaches for cancer therapeutics.

Authors:  Ashim K Mitra; Vibhuti Agrahari; Abhirup Mandal; Kishore Cholkar; Chandramouli Natarajan; Sujay Shah; Mary Joseph; Hoang M Trinh; Ravi Vaishya; Xiaoyan Yang; Yi Hao; Varun Khurana; Dhananjay Pal
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

Review 9.  Receptor binding peptides for target-selective delivery of nanoparticles encapsulated drugs.

Authors:  Antonella Accardo; Luigi Aloj; Michela Aurilio; Giancarlo Morelli; Diego Tesauro
Journal:  Int J Nanomedicine       Date:  2014-03-27

10.  Dynamic magnetic fields remote-control apoptosis via nanoparticle rotation.

Authors:  Enming Zhang; Moritz F Kircher; Martin Koch; Lena Eliasson; S Nahum Goldberg; Erik Renström
Journal:  ACS Nano       Date:  2014-03-20       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.